302 related articles for article (PubMed ID: 31659752)
1. Vaccine innovations for emerging infectious diseases-a symposium report.
Cable J; Srikantiah P; Crowe JE; Pulendran B; Hill A; Ginsberg A; Koff W; Mathew A; Ng T; Jansen K; Glenn G; Permar S; Wilson I; Weiner DB; Weissman D; Rappuoli R
Ann N Y Acad Sci; 2020 Feb; 1462(1):14-26. PubMed ID: 31659752
[TBL] [Abstract][Full Text] [Related]
2. Funding vaccines for emerging infectious diseases.
Wong G; Qiu X
Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
[TBL] [Abstract][Full Text] [Related]
3. Self-disseminating vaccines for emerging infectious diseases.
Murphy AA; Redwood AJ; Jarvis MA
Expert Rev Vaccines; 2016; 15(1):31-9. PubMed ID: 26524478
[TBL] [Abstract][Full Text] [Related]
4. mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
Le T; Sun C; Chang J; Zhang G; Yin X
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215994
[TBL] [Abstract][Full Text] [Related]
5. UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments.
Noad RJ; Simpson K; Fooks AR; Hewson R; Gilbert SC; Stevens MP; Hosie MJ; Prior J; Kinsey AM; Entrican G; Simpson A; Whitty CJM; Carroll MW
Vaccine; 2019 Oct; 37(43):6241-6247. PubMed ID: 31522809
[TBL] [Abstract][Full Text] [Related]
6. The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines.
Pezeshki A; Ovsyannikova IG; McKinney BA; Poland GA; Kennedy RB
Expert Rev Vaccines; 2019 Mar; 18(3):253-267. PubMed ID: 30700167
[TBL] [Abstract][Full Text] [Related]
7. [Development of new vaccines].
González-Romo F; Picazo JJ
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):557-68. PubMed ID: 26341041
[TBL] [Abstract][Full Text] [Related]
8. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
[TBL] [Abstract][Full Text] [Related]
9. Progress in vaccine development for infectious diseases-a Keystone Symposia report.
Cable J; Graham BS; Koup RA; Seder RA; Karikó K; Pardi N; Barouch DH; Sharma B; Rauch S; Nachbagauer R; Forsell MNE; Schotsaert M; Ellebedy AH; Loré K; Irvine DJ; Pilkington E; Tahtinen S; Thompson EA; Feraoun Y; King NP; Saunders K; Alter G; Moin SM; Sliepen K; Karlsson Hedestam GB; Wardemann H; Pulendran B; Doria-Rose NA; He WT; Juno JA; Ataca S; Wheatley AK; McLellan JS; Walker LM; Lederhofer J; Lindesmith LC; Wille H; Hotez PJ; Bekker LG
Ann N Y Acad Sci; 2023 Jun; 1524(1):65-86. PubMed ID: 37020354
[TBL] [Abstract][Full Text] [Related]
10. Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015.
Sobanjo-Ter Meulen A; Abramson J; Mason E; Rees H; Schwalbe N; Bergquist S; Klugman KP
Vaccine; 2015 Nov; 33(47):6388-95. PubMed ID: 26314626
[TBL] [Abstract][Full Text] [Related]
11. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
12. Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Voss G; Jacquet JM; Tornieporth N; Kampmann B; Karron R; Meulen AS; Chen R; Gruber M; Lurie N; Weller C; Cramer JP; Saville M; Darko M
Vaccine; 2021 Dec; 39(51):7357-7362. PubMed ID: 34799142
[TBL] [Abstract][Full Text] [Related]
13. TIPICO IX: report of the 9
Martinón-Torres F; Bosch X; Rappuoli R; Ladhani S; Redondo E; Vesikari T; García-Sastre A; Rivero-Calle I; Gómez-Rial J; Salas A; Martín C; Finn A; Butler R
Hum Vaccin Immunother; 2019; 15(10):2405-2415. PubMed ID: 31158041
[TBL] [Abstract][Full Text] [Related]
14. Toward a transdisciplinary understanding and a global control of emerging infectious diseases.
Gonzalez JP; Lambert G; Legand A; Debré P
J Infect Dev Ctries; 2011 Dec; 5(12):903-5. PubMed ID: 22169793
[TBL] [Abstract][Full Text] [Related]
15. Vaccinomics: a future avenue for vaccine development against emerging pathogens.
de la Fuente J; Contreras M
Expert Rev Vaccines; 2021 Dec; 20(12):1561-1569. PubMed ID: 34582295
[TBL] [Abstract][Full Text] [Related]
16. Accelerated vaccine development against emerging infectious diseases.
Leblanc PR; Yuan J; Brauns T; Gelfand JA; Poznansky MC
Hum Vaccin Immunother; 2012 Jul; 8(7):1010-2. PubMed ID: 22777091
[TBL] [Abstract][Full Text] [Related]
17. Mapping time use in clinical trials for vaccines against emerging infectious diseases.
Mandi H; Yimer SA; Norheim G
Clin Trials; 2021 Jun; 18(3):286-294. PubMed ID: 33653146
[TBL] [Abstract][Full Text] [Related]
18. 5. Infectious disease surveillance designated by the Infectious Disease Control Law, and the situation of emerging/re-emerging infectious diseases in Japan.
Okabe N
Intern Med; 2002 Jan; 41(1):61-2. PubMed ID: 11838598
[No Abstract] [Full Text] [Related]
19. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
Maslow JN
Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
